However, in contrast to the strong cytolytic activity by a control A2-restricted NY-ESO-1-specific CD8+ T cells (ESO-CD8), neither TR-CD4 nor NTR-CD4 were cytotoxic against cancer cells, even when the cancer cells were pulsed with peptide (Fig. 1D). The gene discussed is CD8A; the disease is cancer.